Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy

The first US Food and Drug Administration (FDA)- and EMA-approved oncolytic virus has been available since 2015. However, there are no markers available that would predict benefit for the individual patient. During 2007–2012, we treated 290 patients with advanced chemotherapy-refractory cancers, usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemminki, Otto, Oksanen, Minna, Taipale, Kristian, Liikanen, Ilkka, Koski, Anniina, Joensuu, Timo, Kanerva, Anna, Hemminki, Akseli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035494/
https://www.ncbi.nlm.nih.gov/pubmed/29989063
http://dx.doi.org/10.1016/j.omto.2018.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035494/
https://www.ncbi.nlm.nih.gov/pubmed/29989063
http://dx.doi.org/10.1016/j.omto.2018.04.003

Ejemplares similares